[HTML][HTML] An overview of immunotherapeutic approaches against canine visceral leishmaniasis: what has been tested on dogs and a new perspective on improving …

AAM Gonçalves, JC Leite, LA Resende… - Frontiers in Cellular …, 2019 - frontiersin.org
Visceral leishmaniasis (VL), caused by digenetic protozoa of the genus Leishmania, is the
most severe form of leishmaniasis. Leishmania infantum is one of the species responsible …

Visceral leishmaniasis: an overview of vaccine adjuvants and their applications

S Ratnapriya, AA Sahasrabuddhe, A Dube - Vaccine, 2019 - Elsevier
Although there has been an extensive research on vaccine development over the last
decade and some vaccines have been commercialized for canine visceral leishmaniasis …

Immunotherapy in clinical canine leishmaniosis: a comparative update

M Baxarias, P Martínez-Orellana, G Baneth… - Research in veterinary …, 2019 - Elsevier
Leishmaniosis due to Leishmania infantum is a complex infection that can affect both
humans and dogs, and present a wide range of clinical signs and clinicopathological …

Cloning and molecular characterization of thiol-specific antioxidant gene of Leishmania tropica Turkey isolate

H ÖZAVCI, M Kaplan - Turkish Journal of Medical Sciences, 2019 - journals.tubitak.gov.tr
Background/aim: Thiol-specific antioxidant (TSA) protein is one of the most promising
molecules among candidates for vaccine against cutaneous leishmaniasis. It was found to …

[引用][C] Leishmania tropicaya karşı DNA aşı adayı thiol spesific antioxidant geninin klonlanması ve gen diziliminin belirlenmesi

H Özavci - platform.almanhal.com
منصة المنهل لقد انتهت الجلسة. يرجى العمل على إعادة تحديث الصفحة إعادة تحديث يرجى الانتظار...
يتم تحضير الملف الاستخدام المجاني إذا كنت ترغب في الوصول الكامل إلى هذا المحتوى وقاعدة …